Skip to main content

Table 2 General characteristics of the study population

From: Plasmodium falciparum multiplicity of infection and pregnancy outcomes in Congolese women from southern Brazzaville, Republic of Congo

Variables

Microscopic infected women n = 27

Submicroscopic infected women n = 223

p value

Age in years (median with IQR)

23 (20; 27)

25 (21; 31)

0.027

 ≤ 20 years

7/27 (25.9%)

44/223 (19.7%)

0.45

 21–30 years

18/27 (66.7%)

118/223 (52.9%)

0.22

 > 30 years

2/27 (7.4%)

60/223 (26.9%)

0.03

Parity (mean ± SD)

2.1 ± 1.0

2.7 ± 1.5

0.05

Gravidity (mean ± SD)

2.2 ± 1.1

3.2 ± 1.7

0.008

Primigravidae

8/27 (29.6%)

42/223 (18.8%)

0.20

Secundigravidae

8/27 (29.6%)

47/223 (21.1%)

0.33

Multigravidae

11/27 (40.7%)

134/223 (60.0%)

0.06

Haemoglobin level in (g/dL) (median with IQR)

10.05 (8.45; 12.60)

11.60 (10.30; 13.00)

0.011

Maternal anaemia (Hb < 11 g/dL)

16/26 (61.5%)

80/221 (36.2%)

0.02

Gestational age in weeks (median with IQR)

38 (36; 39)

38 (37; 39)

0.06

msp-1 DNA positive individuals

27 (100%)

223 (100%)

1

Preterm delivery (GA < 37 weeks)

7/27 (25.9%)

39/223 (17.5%)

0.28

Birth weight in g (mean ± SD)

3081 ± 0.449

3130 ± 0.482

0.62

Baby low birth weight

2/27 (7.4%)

17/223(7.6%)

1.00

IPT-SP usage

 Doses of SP (mean ± SD)

1.2 ± 0.9

1.7 ± 1.0

0.020

 0 Dose of SP

6/27 (22.2%)

54/343 (15.7%)

0.41

 1 Dose of SP

13/27 (48.1%)

90/343 (26.2%)

0.02

 2 Doses of SP

4/27 (14.8%)

91/343 (26.5%)

0.25

 3 Doses of SP

4/27 (14.8%)

108/343 (31.9%)

0.08

Women using ITNs

27/27 (100%)

222/343 (64.7%)

 < 0.0001

  1. IQR interquartile ranges), SP Sulfadoxine-pyrimethamine, ITNs insecticide-treated net